Sheppard's Health-e Law cover art

Sheppard's Health-e Law

Sheppard's Health-e Law

Written by: with Michael Orlando and Sara Shanti
Listen for free

LIMITED TIME OFFER | Get 2 Months for ₹5/month

About this listen

 A podcast dedicated to the exciting, and sometimes explosive, interaction between technology and law in the health space, covering innovations that impact healthcare, like artificial intelligence, virtual reality and wearables. Hosted by Sheppard's Digital Health team, the Health-e Law podcast dives into the legal implications of health-tech you should know about and visits with trailblazing players in the industry.Copyright © 2026 Sheppard. All Rights Reserved. Politics & Government
Episodes
  • J.P. Morgan Healthcare 2026 and Beyond: Regulation, Technology and the Future of Health Equity

    J.P. Morgan Healthcare 2026 and Beyond: Regulation, Technology and the Future of Health Equity
    Mar 5 2026
    Welcome to Health-e Law, Sheppard's podcast exploring the fascinating health tech topics and trends of the day. In this episode, partner and host Michael Orlando welcomes Adam Herbst, a partner in Sheppard's Healthcare industry team, to explore key insights from the 2026 J.P. Morgan Healthcare Conference and discuss both the pitfalls and opportunities the One Big Beautiful Bill (OBBBA) presents for the healthcare sector. What we discuss in this episode: What does the increased use of technology in healthcare mean for the aging population? What key considerations should healthcare leaders keep in mind as they adapt to OBBBA when caring for aging populations? Practical challenges providers will encounter as they seek to deploy technology solutions to address additional OBBBA restrictions. How might OBBBA change the way health systems negotiate partnerships or structure payer contracts? What are some positive outcomes that could arise with these changes? Which anticipated changes in healthcare delivery excite you most about the future of health equity? About Adam Herbst Adam Herbst is a nationally regarded authority at the intersection of healthcare law, policy and delivery, with nearly three decades of experience spanning government, health systems, nonprofits and the private sector. He advises on the full range of corporate and transactional healthcare matters including mergers, acquisitions, joint ventures and financings involving hospitals, long-term care facilities, managed care organizations and private equity funds. He is also widely recognized for his mastery of Medicaid law, financing and policy. His Medicaid work includes 1115 waivers, state-directed payments, managed care contracting, HCBS waiver design, PACE program expansion and long-term care reimbursement across multiple states. Adam regularly structures governance arrangements, negotiates complex management and administrative services agreements and guides providers and investors through multi-state regulatory approvals and compliance regimes. Clients value Adam's ability to combine inside knowledge of government with sophisticated deal experience and a genuine understanding of mission-driven care. Whether guiding a multi-state transaction, structuring a PACE or HCBS program, advising on Medicaid waivers or supporting aging and disability service organizations, he brings a holistic approach that integrates law, policy, operations and strategy, helping clients build sustainable, compliant growth models while advancing care for vulnerable populations. Before joining Sheppard, Adam served as Deputy Commissioner of the New York State Department of Health and as a special advisor to two governors, where he led major initiatives in Medicaid transformation, long-term care reform, and managed care modernization, and chaired New York's Master Plan for Aging. During the COVID-19 pandemic, he played a critical leadership role in the state's emergency response—coordinating with federal partners, standing up COVID-only nursing facilities, managing hospital surge capacity and supporting one of the largest vaccine distribution efforts in the country. His career has also included running a children's hospital, leading a major community health center and advising faith-based organizations and disability service agencies through periods of growth, transformation and financial stress. About Michael Orlando Michael Orlando is a partner in Sheppard's San Diego (Del Mar) office. He is team leader of the firm's Technology Transactions team, a member of the Life Sciences, Healthcare and Artificial Intelligence teams, and co-leader of the firm's Digital Health & Innovation team. Michael has more than 20 years of experience advising health technology companies, insurers, healthcare systems and providers, academic medical centers and research institutions, medical device manufacturers, and pharmaceutical and wellness companies on intellectual property and business transactions in key strategic areas, including EHR systems procurement and integration, telehealth, mobile health applications, clinical decision support technologies, artificial intelligence, data use, wearable devices, remote patient monitoring, and other medical devices, research and collaborations, patent licenses, software licenses, joint ventures, mergers and acquisitions, revenue cycle management, and other outsourcing transactions. Michael founded a software-as-a-service company before entering private practice and completed an in-house secondment at a publicly traded biotechnology company, an experience that informs his practical and business-focused approach to client engagements. Thank you for listening! Don't forget to SUBSCRIBE to the show to receive new episodes delivered straight to your podcast player every month. If you enjoyed this episode, please help us get the word out about this podcast. Rate and Review this show on Apple Podcasts, Amazon Music, or Spotify. It...
    Show More Show Less
    13 mins
  • J.P. Morgan Healthcare 2026 and Beyond: Technology Adoption and Strategic Transformation Under Cost Pressure

    J.P. Morgan Healthcare 2026 and Beyond: Technology Adoption and Strategic Transformation Under Cost Pressure
    Feb 20 2026
    Welcome to Health-e Law, Sheppard's podcast exploring the fascinating health tech topics and trends of the day. In this episode, partner and host Michael Orlando welcomes Eric Newsom, partner and Transactions lead of Sheppard's national Healthcare industry team, to discuss key takeaways from the 2026 J.P. Morgan Healthcare Conference and explore what growing AI adoption, shifting reimbursement models and evolving macroeconomics mean for M&A and strategic partnerships. What we discuss in this episode: How the conference addressed the growing focus on AI-powered healthcare platforms. The key factors driving adoption of AI technologies across the healthcare industry. How providers and payers are adjusting their M&A and joint‑venture strategies amid shifting reimbursement models and evolving macroeconomic pressures. The top three priorities for healthcare leaders when advancing AI adoption and structuring strategic partnerships. Topics not covered at the conference that Eric would have liked to learn more about. About Eric Newsom Eric Newsom is a partner in the Corporate practice group in Sheppard's San Francisco office and serves as Transactions Lead of the firm's national Healthcare industry team. Eric's nationwide practice focuses on mergers and acquisitions, strategic joint ventures, corporate reorganizations, private equity and venture capital transactions, and corporate governance and compliance matters. Eric has represented buyers, sellers, investors, and intermediaries in numerous business combinations, buyouts, and investment transactions, with particular emphasis on the healthcare industry. In his healthcare and health technology practice, Eric advises on mergers, acquisitions, affiliations, comprehensive corporate reorganizations, multi-channel joint ventures, and private equity investment and disposition transactions. His experience spans for-profit, nonprofit, and government-owned hospital and provider systems; academic medical centers; health plans; physician groups; ambulatory and specialty service providers; and startup and growth-stage companies in the healthcare information technology sector. About Michael Orlando Michael Orlando is a partner in Sheppard's San Diego (Del Mar) office. He is team leader of the firm's Technology Transactions team, a member of the Life Sciences, Healthcare and Artificial Intelligence teams, and co-leader of the firm's Digital Health & Innovation team. Michael has more than 20 years of experience advising health technology companies, insurers, healthcare systems and providers, academic medical centers and research institutions, medical device manufacturers, and pharmaceutical and wellness companies on intellectual property and business transactions in key strategic areas, including EHR systems procurement and integration, telehealth, mobile health applications, clinical decision support technologies, artificial intelligence, data use, wearable devices, remote patient monitoring, and other medical devices, research and collaborations, patent licenses, software licenses, joint ventures, mergers and acquisitions, revenue cycle management, and other outsourcing transactions. Michael founded a software-as-a-service company before entering private practice and completed an in-house secondment at a publicly traded biotechnology company, an experience that informs his practical and business-focused approach to client engagements. Contact Info Eric Newsom Michael Orlando Thank you for listening! Don't forget to SUBSCRIBE to the show to receive new episodes delivered straight to your podcast player every month. If you enjoyed this episode, please help us get the word out about this podcast. Rate and Review this show on Apple Podcasts, Amazon Music, or Spotify. It helps other listeners find this show. This podcast is for informational and educational purposes only. It is not to be construed as legal advice specific to your circumstances. If you need help with any legal matter, be sure to consult with an attorney regarding your specific needs.
    Show More Show Less
    19 mins
  • J.P. Morgan Healthcare 2026 and Beyond: How Digital Innovation Shapes Healthcare M&A

    J.P. Morgan Healthcare 2026 and Beyond: How Digital Innovation Shapes Healthcare M&A
    Feb 9 2026
    Welcome to Health-e Law, Sheppard's podcast exploring the fascinating health tech topics and trends of the day. In this episode, partner and host Michael Orlando welcomes Amanda Zablocki, co-leader of Sheppard's Healthcare industry team, to explore key insights from the 2026 J.P. Morgan Healthcare Conference and discuss how digital innovation is transforming the healthcare M&A landscape What We Discuss in This Episode: How did buzzwords like AI and innovation shape conversations at this year's J.P. Morgan Healthcare Conference? What role does technology play in healthcare transactions? How is AI driving the next wave of consolidation among hospitals, health systems and health plans? What are the challenges and opportunities in integrating technology platforms during mergers and acquisitions? How does technology leadership influence whether an organization becomes a buyer, partner or target, and why is it critical to involve technology leaders early in the deal-making process? What is the impact of data assets, analytics platforms and AI-driven tools on healthcare transactions? How can organizations balance the cost of technology with their mission to serve patients and communities? What legal and regulatory considerations should healthcare organizations prioritize when adopting new technologies? About Amanda Zablocki Amanda Zablocki is a partner in the Corporate practice group in Sheppard's New York office and co-leader of the firm's Healthcare Industry team. A trusted legal and strategic advisor to healthcare organizations nationwide, she helps them to achieve their mission and goals while navigating a dynamic regulatory landscape. Large-scale, strategic transactions—mergers and acquisitions, joint ventures and strategic partnerships, and corporate reorganizations—are at the center of Amanda's practice. With extensive industry knowledge, a deep understanding of the key drivers and levers for success, and broad experience navigating the complex healthcare regulatory landscape, she helps clients close high-impact deals that transform healthcare. Amanda's clients include health plans and health insurers, hospital systems, academic medical centers, digital health and healthcare technology companies, pharmaceutical and life sciences companies, rare disease organizations, physician practices, management services organizations, value-based care organizations, and 501(c)(3) organizations. Having begun her career in commercial litigation, she brings a litigator's eye to managing risk in connection with disputes and advocating her clients' positions. Amanda co-founded Sheppard's Women in Healthcare Leadership Collaborative, an exclusive initiative that provides support to women professionals in the healthcare and life sciences industries. She is also co-founder and a board member of Hyper IgM Foundation, an organization committed to improving the treatment, quality of life and long-term outlook for children and adults living with Hyper IgM. About Michael Orlando Michael Orlando is a partner in Sheppard's San Diego (Del Mar) office. He is team leader of the firm's Technology Transactions team, a member of the Life Sciences, Healthcare and Artificial Intelligence teams, and co-leader of the firm's Digital Health team. Michael has more than 20 years of experience advising health technology companies, insurers, healthcare systems and providers, academic medical centers and research institutions, medical device manufacturers, and pharmaceutical and wellness companies on intellectual property and business transactions in key strategic areas, including EHR systems procurement and integration, telehealth, wearable devices, remote patient monitoring, mobile health applications, clinical decision support technologies, artificial intelligence, data use, research and collaborations, patent licenses, software licenses, joint ventures, mergers and acquisitions, revenue cycle management, and other outsourcing transactions. Before entering private practice, Michael founded a software-as-a-service company and completed an in-house secondment at a publicly traded biotechnology company, an experience that informs his practical and business-focused approach to client engagements. Contact Info Amanda Zablocki Michael Orlando Resources Women in Leadership Healthcare Collaborative (WHLC) Thank you for listening! Don't forget to SUBSCRIBE to the show to receive new episodes delivered straight to your podcast player every month. If you enjoyed this episode, please help us get the word out about this podcast. Rate and Review this show on Apple Podcasts, Amazon Music, or Spotify. It helps other listeners find this show. This podcast is for informational and educational purposes only. It is not to be construed as legal advice specific to your circumstances. If you need help with any legal matter, be sure to consult with an attorney regarding your specific needs.
    Show More Show Less
    18 mins
No reviews yet